Personalized treatment study for bone disease in kidney failure
Part of Bones, joints & muscles, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial looks at a personalized approach to diagnosing and treating bone problems caused by long-term kidney disease. It may help by matching treatment plans to the type of bone turnover found in your tests or biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older) and can give informed consent
- You have chronic kidney disease stages 3 through 5D (including people on dialysis)
- You have a medical reason to be treated for kidney-related high parathyroid hormone, bone weakness, or osteoporosis
- Your blood tests show a specific pattern (or your bone biopsy shows a specific pattern) of “low” or “high” bone turnover
- You are not in another drug/device study or have not been in one in the last 30 days
- You should not be planning a kidney transplant during the study or soon after a transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests teriparatide (a hormone-like bone medicine) to improve bone health in people with advanced chronic kidney disease who are at risk for weak, low-turnover bone. It may help by changing how quickly your bones break down and rebuild.
This study checks how kidney disease affects bone health by measuring hormones like PTH and related blood markers. It may help doctors better diagnose bone problems that can occur with poor kidney function.
This trial looks at how well an integrated program for identifying and treating people at risk for chronic kidney disease (CKD) can improve outcomes. It may help by catching problems earlier and guiding treatment sooner.
This trial tests whether regulating parathyroid hormone (PTH) can improve bone density in people with advanced chronic kidney disease (CKD) who are not on dialysis. It may help you if you have stage 4-5 CKD and high PTH levels.
This study looks at bone and mineral disorders in people on dialysis, after a kidney transplant, or with bone thinning. It aims to understand how these conditions affect bone health.
This study is a follow-up for people who completed a previous precision medicine trial for osteoporosis. It will monitor your bone health to see how well the treatment is working over time.
Hear when a new Secondary Hyperparathyroidism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.